2023 Form 5500 filing — Ipsen Biopharmaceuticals, Inc. U.S. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241004123137NAL0005694467001) for Ipsen Biopharmaceuticals, Inc. U.S. 401(K) Plan, reported by Ipsen Biopharmaceuticals, Inc under EIN 26-0042539 and plan number 001. It reports 1,063 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241004123137NAL0005694467001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Ipsen Biopharmaceuticals, Inc
- EIN
- 26-0042539
- Plan number
- 001
- Location
- Berkeley Heights, NJ
- Participants
- 1,063
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $165,883,134
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $165,883,134
- Employer contributions
- $14,494,898
- Participant contributions
- $13,875,402
- Total income / additions
- $61,790,092
- Benefits paid
- $20,818,373
- Administrative expenses
- $92,432
- Total expenses
- $20,928,497
- Net increase / (decrease)
- $40,861,595
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | $92,432 | $0 |